Numeral (Pharmaceuticals) Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Stock Symbol
  • GOLI.N0000

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.01
  • (As of Wednesday Closing)

Numeral (Pharmaceuticals) General Information

Description

Numeral Ltd is a multi-faceted healthcare company offering a comprehensive all-inclusive product range that addresses market needs from pharmaceutical, generic, nutraceutical, medical consumables through to high end sophisticated hospital equipment.

Contact Information

Formerly Known As
Go Life International
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Shop 10A & 10B, Woodmill Lane Centre
  • Main Street, Knysna Central
  • Knysna, 6571
  • South Africa
+27 081
Primary Industry
Pharmaceuticals
Other Industries
Food Products
Stock Exchange
XMAU
Vertical(s)
Corporate Office
  • Shop 10A & 10B, Woodmill Lane Centre
  • Main Street, Knysna Central
  • Knysna, 6571
  • South Africa
+27 081

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Numeral (Pharmaceuticals) Stock Performance

As of 22-Jan-2025, Numeral (Pharmaceuticals)’s stock price is $0.01. Its current market cap is $12.4M.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.01 $12.4M 9.9K

Numeral (Pharmaceuticals) Financials Summary

As of 30-Nov-2022, Numeral (Pharmaceuticals) has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Nov-2022 FY 2022 28-Feb-2022 FY 2021 28-Feb-2021 FY 2020 29-Feb-2020
EV 9,000 9,000 9,000
Revenue 0 0 0 0
EBITDA (97) (63) (261)
Net Income (97) (63) (261) (35,258)
Total Assets 1 1 1 1
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Numeral (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Numeral (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Numeral (Pharmaceuticals) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Numeral (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Numeral (Pharmaceuticals) Acquisitions (1)

Numeral (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with BonHealthcare. The deal was made on 01-Jan-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BonHealthcare 01-Jan-2016 Merger/Acquisition Elder and Disabled Care
To view Numeral (Pharmaceuticals)’s complete acquisitions history, request access »

Numeral (Pharmaceuticals) FAQs

  • When was Numeral (Pharmaceuticals) founded?

    Numeral (Pharmaceuticals) was founded in 2010.

  • Where is Numeral (Pharmaceuticals) headquartered?

    Numeral (Pharmaceuticals) is headquartered in Knysna, South Africa.

  • What industry is Numeral (Pharmaceuticals) in?

    Numeral (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Numeral (Pharmaceuticals) a private or public company?

    Numeral (Pharmaceuticals) is a Public company.

  • What is Numeral (Pharmaceuticals)’s stock symbol?

    The ticker symbol for Numeral (Pharmaceuticals) is GOLI.N0000.

  • What is the current stock price of Numeral (Pharmaceuticals)?

    As of 22-Jan-2025 the stock price of Numeral (Pharmaceuticals) is $0.01.

  • What is the current market cap of Numeral (Pharmaceuticals)?

    The current market capitalization of Numeral (Pharmaceuticals) is $12.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »